TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16915367

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg after pretreatment with clarithromycin 800 mg/day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg after pretreatment with fluvoxamine 50 mg/day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 15736352

Group type: EXPERIMENTAL
Intervention: Cyclizine 0.7 mg/kg during surgery followed by PCA with cyclizine 2 mg per demand
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Droperidol 0.04 mg/kg during surgery followed by PCA with droperidol 0.05 mg per demand
Number of subjects: 30
Study: 10598606

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg rapacuronium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg rapacuronium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Succinylcholine (1.0 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mivacurium (0.25 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: All groups (1.5 mg/kg rapacuronium, 2.5 mg/kg rapacuronium, succinylcholine, mivacurium)
Number of subjects: 0
Study: 8595286

Group type: EXPERIMENTAL
Intervention: New style care (reduced schedule of visits)
Number of subjects: 2794
Study: 1927129

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with Cisplatin and 5‐Fluorouracil over 6 cycles
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with Cisplatin and 5‐Fluorouracil over 3 cycles plus Telecobalt‐irradiation to 50 Gy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Postoperative irradiation with Telecobalt to 50 Gy
Number of subjects: 41
Study: 6886479

Group type: EXPERIMENTAL
Intervention: 14-valent pneumococcal vaccine
Number of subjects: 249
Study: 31185919

Group type: EXPERIMENTAL
Intervention: Bilateral thoracic paravertebral block combined with general anesthesia (PVB + GA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 60
Study: 27974316

Group type: COMPARATOR
Intervention: Nondiabetic obese adults
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lean healthy adults
Number of subjects: 24
Study: 25539762

Group type: EXPERIMENTAL
Intervention: Diazepam (15 mg daily for 7 days)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 24066672

Group type: EXPERIMENTAL
Intervention: 80 μg Beraprost Sodium (BPS) daily for 12 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 21852698

Group type: EXPERIMENTAL
Intervention: Primary care at time of pregnancy confirmation with parallel partner testing (n = 191)
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Primary care at time of pregnancy confirmation with sequential partner testing (n = 158)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Secondary care by midwives with sequential partner testing (standard care, n = 115)
Number of subjects: 464
Study: 19290709

Group type: EXPERIMENTAL
Intervention: Information based on social cognitive theory (SCT) targeting outcome expectations
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Information based on SCT + elaboration likelihood model
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Feedback based on self‐perception theory
Number of subjects: 251

Group type: COMPARATOR
Intervention: Control
Number of subjects: 251
Study: 17368619

Group type: EXPERIMENTAL
Intervention: Spanish generic reference pricing system for lovastatin
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Spanish generic reference pricing system for simvastatin
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Public interventions in Spain
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Public interventions in Andalusia
Number of subjects: 46
Study: 14734066

Group type: EXPERIMENTAL
Intervention: Lidocaine buffered with sodium bicarbonate (pH 7.4)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Plain lidocaine (pH 6.4)
Number of subjects: 64
Study: 11467693

Group type: EXPERIMENTAL
Intervention: 2% clindamycin vaginal cream
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 168
Study: 9507926

Group type: EXPERIMENTAL
Intervention: Incorrect irregular participle forms (e.g., *prendato instead of preso)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Incorrect regular participle forms (e.g., *parlito, *dormato)
Number of subjects: 12
Study: 7530028

Group type: EXPERIMENTAL
Intervention: Methoxamine 10 mg i.m. 15 min before spinal anaesthesia
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no methoxamine)
Number of subjects: 36
Study: 3123118

Group type: EXPERIMENTAL
Intervention: gamma-L-glutamyl-L-dopa (gludopa) at a dose of 25 micrograms min-1 kg-1
Number of subjects: 6

Group type: COMPARATOR
Intervention: gamma-L-glutamyl-L-tyrosine (glutyrosine) at a dose of 25 micrograms min-1 kg-1
Number of subjects: 6
Study: 31926169

Group type: EXPERIMENTAL
Intervention: Microscopic colitis
Number of subjects: 13957
Study: 30917121

Group type: EXPERIMENTAL
Intervention: Combination-prevention-package (behaviour change communication, condom promotion, HIV testing, voluntary male medical circumcision, referral for anti-retroviral therapy if HIV-positive)
Number of subjects: 862

Group type: EXPERIMENTAL
Intervention: Combination-prevention-package
Number of subjects: 862

Group type: COMPARATOR
Intervention: Routine government HIV care services (Control)
Number of subjects: 862

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 862
Study: 29141719

Group type: EXPERIMENTAL
Intervention: Chloroquine plus primaquine (0.25 mg base/kg/day for 14 days)
Number of subjects: 593

Group type: COMPARATOR
Intervention: Chloroquine alone
Number of subjects: 593
Study: 25418212

Group type: EXPERIMENTAL
Intervention: CABG + BMMNC
Number of subjects: 42

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 42
Study: 23965321

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21831064

Group type: EXPERIMENTAL
Intervention: Hybrid school-based nutrition education program
Number of subjects: 12
Study: 20000249

Group type: EXPERIMENTAL
Intervention: Structured classroom and clinical content related to safety and quality of health care systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Classroom and clinical learning activities
Number of subjects: 0
Study: 17100735

Group type: EXPERIMENTAL
Intervention: 8-MOP/NB-UVB
Number of subjects: 10

Group type: COMPARATOR
Intervention: NB-UVB
Number of subjects: 10
Study: 14707788

Group type: EXPERIMENTAL
Intervention: GW433908 (908), 1400 mg BID
Number of subjects: 166

Group type: COMPARATOR
Intervention: Nelfinavir (NFV), 1250 mg BID
Number of subjects: 166
Study: 11595607

Group type: EXPERIMENTAL
Intervention: Angiotensin II
Number of subjects: 20

Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 20
Study: 9440358

Group type: EXPERIMENTAL
Intervention: Bilateral elbow movements with frequency ratios of 2:1 and 3:1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional practice in the second experiment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent approach toward a 1:1 ratio within each cycle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sufficient practice to perform movements smoothly
Number of subjects: 0
Study: 7942719

Group type: EXPERIMENTAL
Intervention: Endoscopic therapy (injection or heater probe therapy)
Number of subjects: 326
Study: 2681281

Group type: EXPERIMENTAL
Intervention: Sulconazole nitrate 1% cream applied twice daily
Number of subjects: 229

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 229
Study: 1090014

Group type: EXPERIMENTAL
Intervention: d‐tubocurarine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: THA (tetrahydro-aminacrine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No additional drugs (Control Group I)
Number of subjects: 0
Study: 30496547

Group type: EXPERIMENTAL
Intervention: Dance Movement Therapy (DMT)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Physical Exercise
Number of subjects: 204

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 204
Study: 29309700

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (800 mcg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intravenous buprenorphine (300 mcg)
Number of subjects: 14
Study: 27638847

Group type: EXPERIMENTAL
Intervention: Multivariable risk prediction model
Number of subjects: 6083

Group type: EXPERIMENTAL
Intervention: Final multivariable model
Number of subjects: 6083
Study: 25542198

Group type: EXPERIMENTAL
Intervention: Positively framed feedback
Number of subjects: 59

Group type: COMPARATOR
Intervention: Negatively framed feedback
Number of subjects: 59
Study: 23553992

Group type: EXPERIMENTAL
Intervention: 400 or 2000 IU vitamin D3 daily for 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher supplementation with vitamin D
Number of subjects: 0
Study: 21292711

Group type: EXPERIMENTAL
Intervention: Training in a modified version of the neonatal resuscitation protocol and single dose amoxicillin coupled with facilitated referral of infants to a health centre
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control birth attendants continued their existing standard of care (basic obstetric skills and use of clean delivery kits)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Training in a modified version of the neonatal resuscitation protocol
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control birth attendants continued their existing standard of care
Number of subjects: 127
Study: 19691854

Group type: EXPERIMENTAL
Intervention: Clonidine (initial loading dose of 0.15 mg followed by an infusion of 0.5 mg over 24 hours; increased to 0.3 mg, 0.45 mg, and 0.6 mg at subsequent levels)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 16478814

Group type: EXPERIMENTAL
Intervention: Testosterone administration using a patch that delivers 300 microg daily
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 15577594

Group type: EXPERIMENTAL
Intervention: Artificial neural networks (ANNs) for diagnosing pulmonary embolism using V-P scan analysis
Number of subjects: 262

Group type: COMPARATOR
Intervention: Clinical interpretation of V-P scans
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Combination of ANN and clinical interpretation
Number of subjects: 262
Study: 11041065

Group type: EXPERIMENTAL
Intervention: Single cytospin slide preparation
Number of subjects: 129
Study: 9001831

Group type: COMPARATOR
Intervention: Ranitidine 150 mg BID
Number of subjects: 696

Group type: COMPARATOR
Intervention: Cimetidine 800 mg BID
Number of subjects: 696

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg QID
Number of subjects: 696
Study: 1603146

Group type: EXPERIMENTAL
Intervention: Simple ligation
Number of subjects: 134

Group type: COMPARATOR
Intervention: Invagination
Number of subjects: 134
Study: 6384453

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ) administered twice daily
Number of subjects: 77

Group type: COMPARATOR
Intervention: Cefaclor administered twice daily
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Both TMP-SMZ and cefaclor
Number of subjects: 77
Study: 29652596

Group type: EXPERIMENTAL
Intervention: 100% feedback
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 67% feedback
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reduced feedback (67%)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both feedback groups (100% and 67%)
Number of subjects: 30
Study: 28368521

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: AVP
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CRH
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: CRH-AVP
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Bolus AVP after CRH infusion
Number of subjects: 28

Group type: COMPARATOR
Intervention: Bolus CRH
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 28
Study: 28003295

Group type: EXPERIMENTAL
Intervention: Individualised patient falls prevention education delivered by a trained health professional
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Individualised patient falls prevention education
Number of subjects: 30
Study: 25403218

Group type: EXPERIMENTAL
Intervention: P‐ISG
Number of subjects: 184

Group type: COMPARATOR
Intervention: S‐ISG
Number of subjects: 184
Study: 21422032

Group type: EXPERIMENTAL
Intervention: Electrical cardioversion (EC)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Intravenous propafenone treatment (PC)
Number of subjects: 247
Study: 19735195

Group type: EXPERIMENTAL
Intervention: Borage oil enriched with vitamin E
Number of subjects: 24

Group type: COMPARATOR
Intervention: No supplementation (Control)
Number of subjects: 24
Study: 17533063

Group type: EXPERIMENTAL
Intervention: Lifestyle change group
Number of subjects: 240

Group type: COMPARATOR
Intervention: Health education group
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: HRT discontinuation
Number of subjects: 240
Study: 15345498

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg injections, twice weekly for 12 weeks)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 11141221

Group type: EXPERIMENTAL
Intervention: 1.5 g intravenous ampicillin and sulbactam (AS) before incision
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study: 11885450

Group type: EXPERIMENTAL
Intervention: Ketoconazole 2% (K)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nystatin 100,000 IU (N)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 24
Study: 7733785

Group type: EXPERIMENTAL
Intervention: sulperazone (cefoperazone + sulbactam)
Number of subjects: 25
Study: 2914116

Group type: EXPERIMENTAL
Intervention: ioxaglate 280 mg I/ml
Number of subjects: 25

Group type: COMPARATOR
Intervention: metrizoate 280 mg I/ml
Number of subjects: 25

Group type: COMPARATOR
Intervention: metrizoate 370 mg I/ml
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: ioxaglate 320 mg I/ml
Number of subjects: 25
Study: 4262210

Group type: EXPERIMENTAL
Intervention: Carisoprodol 350 mg, four times daily for four days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Butabarbital 15 mg, four times daily for four days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo, four times daily for four days
Number of subjects: 48
Study: 31156218

Group type: EXPERIMENTAL
Intervention: Comprehensive rehabilitation including mechanotherapy and cognitive stimulation using tablet technologies
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 100
Study: 28005440

Group type: EXPERIMENTAL
Intervention: High-dose cholecalciferol (300,000 IU)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-dose cholecalciferol (75,000 IU)
Number of subjects: 24
Study: 25988518

Group type: EXPERIMENTAL
Intervention: Perineural invasion present
Number of subjects: 302

Group type: COMPARATOR
Intervention: No perineural invasion
Number of subjects: 302
Study: 23754314

Group type: EXPERIMENTAL
Intervention: Endometrial scratching with a pipelle de Cornier
Number of subjects: 158

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 158
Study: 21802681

Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chromoendoscopy (CE)
Number of subjects: 60
Study: 19622875

Group type: EXPERIMENTAL
Intervention: UniFil Bond (UB) with regular-grit diamond bur
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Adper Single Bond (SB) with regular-grit diamond bur
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Adper Single Bond (SB) with superfine-grit diamond bur
Number of subjects: 2
Study: 16963037

Group type: EXPERIMENTAL
Intervention: Single-dose GnRH antagonist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long protocol for GnRH agonist
Number of subjects: 0
Study: 15319595

Group type: EXPERIMENTAL
Intervention: Minimally invasive radioguided surgery (MIRS)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Traditional bilateral neck exploration (BNE)
Number of subjects: 266
Study: 10979147

Group type: EXPERIMENTAL
Intervention: Intensive group education on the Mediterranean diet
Number of subjects: 266

Group type: COMPARATOR
Intervention: Posted leaflet with Dutch nutritional guidelines
Number of subjects: 266
Study: 9538647

Group type: EXPERIMENTAL
Intervention: Dialyzed patients with chronic renal insufficiency
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hemodialysis with the presence of heparin
Number of subjects: 40
Study: 1539790

Group type: EXPERIMENTAL
Intervention: Graseby electronic patient‐controlled analgesia system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Baxter disposable patient‐controlled analgesia system
Number of subjects: 30
Study: 2862652

Group type: EXPERIMENTAL
Intervention: Pl haloperidol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RBC haloperidol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SS RBC haloperidol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal clinical response range for Pl haloperidol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal clinical response range for RBC haloperidol
Number of subjects: 0
Study: 29532196

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) using GaAlAs diode laser (780 nm, 2 J/spot) applied immediately after surgery and every 24 hours for 3 days.
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no laser therapy).
Number of subjects: 82
Study: 27254260

Group type: EXPERIMENTAL
Intervention: Low quadriceps group (LSI < 85%)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: High quadriceps group (LSI ≥ 90%)
Number of subjects: 135
Study: 23558454

Group type: EXPERIMENTAL
Intervention: Orofacial regulation therapy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (no mimicry therapy)
Number of subjects: 99
Study: 23510321

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) scalpel (LigaSure; n=66)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Ultrasound (US) scalpel (UltraCision; n=66)
Number of subjects: 132
Study: 20502743

Group type: EXPERIMENTAL
Intervention: Nasal insulin
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 18701642

Group type: EXPERIMENTAL
Intervention: Pycnogenol (150 mg daily for 3 months)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 101
Study: 16306318

Group type: EXPERIMENTAL
Intervention: Sponges with high content of saline placed in the olfactory cleft (OC)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sponges with high content of saline placed on the respiratory epithelium
Number of subjects: 33
Study: 12818461

Group type: EXPERIMENTAL
Intervention: 1 mg estradiol
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: 2 mg estradiol
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 10083765

Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg per day
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 300 mg twice per day
Number of subjects: 25
Study: 7729302

Group type: EXPERIMENTAL
Intervention: Euglycemic hyperinsulinemic clamp (40 mU insulin.m-2.min-1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo infusion (50 ml isotonic saline)
Number of subjects: 16
Study: 2292327

Group type: EXPERIMENTAL
Intervention: 0.1% mometasone furoate cream applied once daily
Number of subjects: 69

Group type: COMPARATOR
Intervention: 0.1% betamethasone valerate cream applied twice daily
Number of subjects: 69
Study: 6156665

Group type: EXPERIMENTAL
Intervention: Continuous feedback of erection changes plus segments of erotic film delivered contingent on erection increases
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Contingent film segments without continuous feedback
Number of subjects: 30

Group type: COMPARATOR
Intervention: Noncontingent film segments
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Contingent film without continuous feedback
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self-report measures concerning erectile functioning during a 1-month follow-up period
Number of subjects: 30
Study: 31971158

Group type: EXPERIMENTAL
Intervention: Free-trial group (257 households)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Cost-sharing group (240 households)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Cost-sharing group
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Households with high and medium economic status
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Households with higher educated respondents
Number of subjects: 497
Study: 30517622

Group type: EXPERIMENTAL
Intervention: Tricuspid valve annuloplasty (TVP+)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conservative treatment (TVP-)
Number of subjects: 106
Study: 29028775

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercises
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25921551

Group type: EXPERIMENTAL
Intervention: Modafinil (200mg/day)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 23505172

Group type: EXPERIMENTAL
Intervention: Metformin (2,000 mg/d)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Exercise training plus placebo
Number of subjects: 32
Study: 21057356

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (transfusion if hemoglobin <7.0 g/dL)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Liberal transfusion strategy (transfusion if hemoglobin <9.5 g/dL)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 137
Study: 20581790

Group type: EXPERIMENTAL
Intervention: TzCOAD (150-375 mg)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 412
Study: 16527562

Group type: EXPERIMENTAL
Intervention: Shock Wave Lithotripsy (SWL)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ureteroscopic Lithotripsy (URSL)
Number of subjects: 42